loading
前日終値:
$13.84
開ける:
$13.84
24時間の取引高:
23,079
Relative Volume:
0.49
時価総額:
$80.65M
収益:
-
当期純損益:
$-31.48M
株価収益率:
-13.13
EPS:
-1.04
ネットキャッシュフロー:
$-28.71M
1週間 パフォーマンス:
+19.72%
1か月 パフォーマンス:
+43.04%
6か月 パフォーマンス:
-44.24%
1年 パフォーマンス:
+7.14%
1日の値動き範囲:
Value
$13.35
$14.49
1週間の範囲:
Value
$10.91
$14.49
52週間の値動き範囲:
Value
$4.11
$28.68

Forte Biosciences Inc Stock (FBRX) Company Profile

Name
名前
Forte Biosciences Inc
Name
セクター
Healthcare (1166)
Name
電話
(310) 618-6994
Name
住所
3060 PEGASUS PARK DRIVE, DALLAS, CA
Name
職員
14
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
FBRX's Discussions on Twitter

FBRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
FBRX
Forte Biosciences Inc
13.71 80.65M 0 -31.48M -28.71M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-21 開始されました TD Cowen Buy
2024-04-08 アップグレード Ladenburg Thalmann Neutral → Buy
2021-09-20 アップグレード Chardan Capital Markets Sell → Buy
2021-09-03 ダウングレード B. Riley Securities Buy → Neutral
2021-09-03 ダウングレード Chardan Capital Markets Buy → Sell
2021-09-03 ダウングレード Ladenburg Thalmann Buy → Neutral
2021-09-03 ダウングレード Truist Buy → Hold
2021-05-14 開始されました B. Riley Securities Buy
2021-03-26 開始されました Citigroup Buy
2020-08-28 アップグレード Chardan Capital Markets Neutral → Buy
2020-08-25 開始されました Truist Buy
すべてを表示

Forte Biosciences Inc (FBRX) 最新ニュース

pulisher
Jun 12, 2025

Valkyrie Balance Sheet Opportunities ETF (NYSEARCA:VBB) Trading 0.4% Higher – Here’s Why - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Traders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

With Forte Biosciences Up 28%, Insider Buyers Count Their Returns - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

(FBRX) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 05, 2025

Forte Biosciences (FBRX) Receives Buy Rating as FB-102 Shows Blockbuster Potential | FBRX Stock News - GuruFocus

Jun 05, 2025
pulisher
May 30, 2025

Forte Biosciences reports annual meeting results By Investing.com - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

Forte Biosciences reports annual meeting results - Investing.com

May 30, 2025
pulisher
May 30, 2025

Forte Biosciences Elects New Directors at Annual Meeting - TipRanks

May 30, 2025
pulisher
May 29, 2025

Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World

May 29, 2025
pulisher
May 28, 2025

How the (FBRX) price action is used to our Advantage - news.stocktradersdaily.com

May 28, 2025
pulisher
May 28, 2025

Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews

May 28, 2025
pulisher
May 22, 2025

Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews

May 22, 2025
pulisher
May 19, 2025

Pre-market Movers: HCTI, PTIX, BCLI, AFMD... - RTTNews

May 19, 2025
pulisher
May 19, 2025

Top Premarket Decliners - marketscreener.com

May 19, 2025
pulisher
May 16, 2025

Forte Biosciences Reports Increased Losses Amid R&D Expansion - TipRanks

May 16, 2025
pulisher
May 15, 2025

Forte Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025
pulisher
May 15, 2025

Forte Biosciences Q1 Operating Expenses USD 16.124 Million - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Forte Biosciences (FBRX) Advances Trials for FB102 in Celiac Disease and Vitiligo | FBRX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Forte Biosciences reports Q1 EPS ($1.37), consensus (95c) - TipRanks

May 15, 2025
pulisher
May 15, 2025

Forte Biosciences, Inc. Announces Results and Provides Update - Eagle-Tribune

May 15, 2025
pulisher
May 15, 2025

Forte Biosciences Q1: Celiac Disease Trial Results Imminent, New Vitiligo Study Launches - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Stock Traders Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

May 15, 2025
pulisher
May 10, 2025

Forte Biosciences (FBRX) Expected to Announce Earnings on Monday - Defense World

May 10, 2025
pulisher
May 08, 2025

JPMorgan Chase & Co. Trims Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World

May 08, 2025
pulisher
May 08, 2025

Royal Bank of Canada Has Lowered Expectations for Zimmer Biomet (NYSE:ZBH) Stock Price - Defense World

May 08, 2025
pulisher
May 08, 2025

JPMorgan Chase & Co. Buys New Holdings in Innovator U.S. Equity Accelerated ETF – January (BATS:XDJA) - Defense World

May 08, 2025
pulisher
May 08, 2025

(FBRX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 08, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Boosts Stock Position in AmpliTech Group, Inc. (NASDAQ:AMPG) - Defense World

May 03, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Increases Position in Forte Biosciences, Inc. (NASDAQ:FBRX) - Defense World

May 03, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Increases Position in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

May 03, 2025
pulisher
May 01, 2025

Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte Corp - Barchart.com

May 01, 2025
pulisher
May 01, 2025

Meta Doubles Down on AI: Is the Stock Ready to Skyrocket? - The Globe and Mail

May 01, 2025
pulisher
Apr 19, 2025

Shining a Light on IL-13: Optimizing Moderate-to-Severe Atopic Dermatitis Treatment in Daily Practice - Healio

Apr 19, 2025
pulisher
Apr 18, 2025

Forte Biosciences sets Annual Meeting for May 29 By Investing.com - Investing.com Canada

Apr 18, 2025
pulisher
Apr 18, 2025

Forte Biosciences sets Annual Meeting for May 29 - Investing.com Australia

Apr 18, 2025
pulisher
Apr 18, 2025

Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Mr. Ethan Billings recommends paying close attention to biotech stocks - FinancialContent

Apr 17, 2025
pulisher
Apr 15, 2025

Profit from Trump’s Tariff Playbook with TipRanks’ New Comparison Tool - The Globe and Mail

Apr 15, 2025
pulisher
Apr 13, 2025

Nvidia and Broadcom Helped Propel This ETF 18% Higher in a Single Day. Here's Why It's Still a Buy Now. - The Globe and Mail

Apr 13, 2025
pulisher
Apr 07, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 07, 2025
pulisher
Apr 07, 2025

Analysts Issue Forecasts for FBRX Q2 Earnings - Defense World

Apr 07, 2025
pulisher
Apr 07, 2025

Equities Analysts Offer Predictions for FBRX FY2025 Earnings - Defense World

Apr 07, 2025
pulisher
Apr 06, 2025

(FBRX) Investment Analysis - news.stocktradersdaily.com

Apr 06, 2025
pulisher
Apr 04, 2025

All You Need to Know About Forte Biosciences (FBRX) Rating Upgrade to Buy - MSN

Apr 04, 2025
pulisher
Apr 04, 2025

Forte Biosciences (NASDAQ:FBRX) Given New $61.00 Price Target at Chardan Capital - The AM Reporter

Apr 04, 2025
pulisher
Apr 03, 2025

Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World

Apr 03, 2025
pulisher
Apr 03, 2025

Chardan Capital Issues Pessimistic Forecast for Forte Biosciences (NASDAQ:FBRX) Stock Price - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Chardan Adjusts Price Target on Forte Biosciences to $61 From $64, Maintains Buy Rating - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Forte Biosciences Reports 2024 Progress and Financials - TipRanks

Apr 02, 2025
pulisher
Apr 01, 2025

Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans? - Yahoo

Apr 01, 2025
pulisher
Mar 31, 2025

Forte's Celiac Treatment Shows Promise: Zero Dropouts and $58.4M War Chest - Stock Titan

Mar 31, 2025

Forte Biosciences Inc (FBRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Forte Biosciences Inc (FBRX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Wagner Paul A.
SEE REMARKS
Apr 01 '25
Option Exercise
0.00
1,250
0
79,806
Riley Antony A
CHIEF FINANCIAL OFFICER
Jan 01 '25
Option Exercise
0.00
375
0
31,151
Wagner Paul A.
SEE REMARKS
Jan 01 '25
Option Exercise
0.00
1,250
0
78,720
Riley Antony A
CHIEF FINANCIAL OFFICER
Nov 21 '24
Buy
5.55
22,514
124,998
30,776
Riley Antony A
CHIEF FINANCIAL OFFICER
Oct 01 '24
Option Exercise
0.00
375
0
8,395
Wagner Paul A.
SEE REMARKS
Oct 01 '24
Option Exercise
0.00
1,250
0
77,568
$20.39
price down icon 0.34%
$36.24
price down icon 0.27%
$23.15
price up icon 7.69%
$96.83
price down icon 0.40%
$108.13
price up icon 0.15%
biotechnology ONC
$247.47
price up icon 1.13%
大文字化:     |  ボリューム (24 時間):